Nocebo Effects in Concussion: Is All That Is Told Beneficial?
Journal
American journal of physical medicine & rehabilitation
ISSN: 1537-7385
Titre abrégé: Am J Phys Med Rehabil
Pays: United States
ID NLM: 8803677
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
9
8
2019
medline:
1
5
2020
entrez:
9
8
2019
Statut:
ppublish
Résumé
Nocebo effects refer to new or worsening symptoms that develop in response to negative health-related information, beliefs, and/or experiences. In recent years, research on concussion pathophysiology has significantly advanced. Through health campaigns and media coverage, emerging knowledge on the risks of this injury has been quickly disseminated to the public, and nowadays, the public perceives concussions as more hazardous to health than ever before. Although advancements in concussion-related research and care are of great importance and value, we ask in this article whether the increasing negative publicity regarding concussion also carries any latent costs. Are additional nocebo effects being fostered? To do so, we will review the literature on the psychological and neurobiological processes underlying nocebo effects, present a series of clinical studies demonstrating the ways in which nocebos may impact concussion outcomes both clinically and societally, then speculate on further potential mechanisms for nocebo effects in concussion. We conclude with an outline of the specific efforts one may take to minimize nocebo effects in concussion-related care.
Identifiants
pubmed: 31393270
doi: 10.1097/PHM.0000000000001290
pii: 00002060-202001000-00011
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
71-80Références
Colloca L, Miller FG: How placebo responses are formed: a learning perspective. Philos Trans R Soc London 2011;366:1859–69
Polich G, Iaccarino MA, Kaptchuk TJ, et al.: Placebo effects in traumatic brain injury. J Neurotrauma 2018;35:1205–12
Colagiuri B, Schenk LA, Kessler MD, et al.: The placebo effect: from concepts to genes. Neuroscience 2015;307:171–90
Petersen GL, Finnerup NB, Colloca L, et al.: The magnitude of nocebo effects in pain: a meta-analysis. Pain 2014;155:1426–34
Crichton F, Chapman S, Cundy T, et al.: The link between health complaints and wind turbines: support for the nocebo expectations hypothesis. Front Public Health 2014;2:220
Crichton F, Petrie KJ: Health complaints and wind turbines: the efficacy of explaining the nocebo response to reduce symptom reporting. Environ Res 2015;140:449–55
Barsky AJ, Saintfort R, Rogers MP, et al.: Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002;287:622
Petrie KJ, Rief W: Psychobiological mechanisms of placebo and nocebo effects: pathways to improve treatments and reduce side effects. Annu Rev Psychol 2019;70:599–625
Rief W, Avorn J, Barsky AJ: Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 2006;166:155–60
Pedro-Botet J, Rubiés-Prat J: Statin-associated muscle symptoms: beware of the nocebo effect. Lancet 2017;389:2445–6
Jones T, Craig A, Hoy D, et al.: Mass psychogenic illness attributed to toxic exposure at a high school. N Engl J Med 2000;342:96–100
Porsius JT, Claassen L, Woudenberg F, et al.: Nocebo responses to high-voltage power lines: evidence from a prospective field study. Sci Total Environ 2016;543:432–8
Rubin GJ, Burns M, Wessely S: Possible psychological mechanisms for “wind turbine syndrome”. On the windmills of your mind. Noise Health 2014;16:116–22
Petrie KJ, Faasse K, Crichton F, et al.: How common are symptoms? Evidence from a New Zealand national telephone survey. BMJ Open 2014;4:e005374
Dixon KJ: Pathophysiology of traumatic brain injury. Phys Med Rehabil Clin N Am 2017;28:215–25
Signoretti S, Lazzarino G, Tavazzi B, et al.: The pathophysiology of concussion. PM R 2011;3(10 suppl 2):S359–68
Pachman S, Lamba A: Legal aspects of concussion: the ever-evolving standard of care. J Athl Train 2017;52:186–94
Carson A: Concussion, dementia and CTE: are we getting it very wrong? J Neurol Neurosurg Psychiatry 2017;88:462–4
Wiebe D, D'Alonzo B, Harris R, et al.: Association between the experimental kickoff rule and concussion rates in Ivy League Football. JAMA 2018;320:2035–6
Colloca L, Finniss D: Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA 2012;307:567–8
Benedetti F, Lanotte M, Lopiano L, et al.: When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007;147:260–71
Oken BS: Placebo effects: clinical aspects and neurobiology. Brain 2008;131:2812–23
Wager TD, Atlas LY: The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci 2015;16:403–18
Benedetti F, Amanzio M: The placebo response: how words and rituals change the patient's brain. Patient Educ Couns 2011;84:413–9
Kaptchuk TJ: The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med 2002;136:817–25
Hall KT, Lembo AJ, Kirsch I, et al.: Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One 2012;7:e48135
Ongaro G, Kaptchuk TJ: Symptom perception, placebo effects, and the Bayesian brain. Pain 2019;160:1–4
Mahr A, Golmard C, Pham E, et al.: Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo-controlled clinical trials. Pharmacoepidemiol Drug Saf 2017;26:731–41
Barron AJ, Zaman N, Cole GD, et al.: Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information. Int J Cardiol 2013;168:3572–9
Mitsikostas DD, Chalarakis NG, Mantonakis LI, et al.: Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice. Eur J Neurol 2012;19:672–80
Dodd S, Schacht A, Kelin K, et al.: Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials. J Clin Psychiatry 2015;76:702–11
Häuser W, Sarzi-Puttini P, Tölle TR, et al.: Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. Clin Exp Rheumatol 2012;30(6 suppl 74):78–87
Chamsi-Pasha M, Albar M, Chamsi-Pasha H: Minimizing nocebo effect: pragmatic approach. Avicenna J Med 2017;7:139–43
Kaptchuk T: Open-label placebo: reflections on a research agenda. Perspect Biol Med 2018;61:311–34
Rief W, Nestoriuc Y, Von Lilienfeld-Toal A, et al.: Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf 2009;32:1041–56
Amanzio M, Corazzini LL, Vase L, et al.: A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain 2009;146:261–9
Kaptchuk TJ, Stason WB, Davis RB, et al.: Sham device v inert pill: randomised controlled trial of two placebo treatments. Br Med J 2006;332:391–7
Webster RK, Weinman J, Rubin GJ: Medicine-related beliefs predict attribution of symptoms to a sham medicine: a prospective study. Br J Health Psychol 2018;23:436–54
Nestoriuc Y, Orav EJ, Liang MH, et al.: Beliefs about medicines predict non-specific side effects in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2010;62:791–9
Kristensen L, Alten R, Puig L, et al.: Non-pharmacological effects in switching medication: the nocebo effect in switching from originator to biosimilar agent. BioDrugs 2018;32:397–404
Odinet JS, Day CE, Cruz JL, et al.: The biosimilar nocebo effect? A systematic review of double-blinded versus open-label studies. J Manag Care Spec Pharm 2018;24:952–9
Faasse K, Cundy T, Gamble G, et al.: The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects. Psychosom Med 2013;75:90–6
Papadopoulos D, Mitsikostas DD: Nocebo effects in multiple sclerosis trials: a meta-analysis. Mult Scler 2010;16:816–28
Benedetti F, Carlino E, Piedimonte A: Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol 2016;15:736–47
Myers MG, Cairns JA, Singer J: The consent form as a possible cause of side effects. Clin Pharmacol Ther 1987;42:250–3
Gupta A, Thompson D, Whitehouse A, et al.: Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase. Lancet 2017;389:2473–81
Mondaini N, Gontero P, Giubilei G, et al.: Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 2007;4:1708–12
Silvestri A, Galetta P, Cerquetani E, et al.: Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 2003;24:1928–32
Wells RE, Kaptchuk TJ: To tell the truth, the whole truth, may do patients harm: the problem of the nocebo effect for informed consent. Am J Bioeth 2012;12:22–9
Luparello T, Lyons HA, Bleecker ER, et al.: Influences of suggestion on airway reactivity in asthmatic subjects. Psychosom Med 1968;30:819–25
Jewett DL, Fein G, Greenberg MH: A double-blind study of symptom provocation to determine food sensitivity. N Engl J Med 1990;323:429–33
Schweiger A, Parducci A: Nocebo: the psychologic induction of pain. Pavlov J Biol Sci 1981;16:140–3
Lorber W, Mazzoni G, Kirsch I: Illness by suggestion: expectancy, modeling, and gender in the production of psychosomatic symptoms. Ann Behav Med 2007;33:112–6
Mazzoni G, Foan L, Hyland ME, et al.: The effects of observation and gender on psychogenic symptoms. Health Psychol 2010;29:181–5
Dworkin SF, Chen AC, LeResche L, et al.: Cognitive reversal of expected nitrous oxide analgesia for acute pain. Anesth Analg 1983;62:1073–7
Aslaksen PM, Zwarg ML, Eilertsen HI, et al.: Opposite effects of the same drug: reversal of topical analgesia by nocebo information. Pain 2015;156:39–46
Flaten MA, Simonsen T, Olsen H: Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 1999;61:250–5
Zunhammer M, Ploner M, Engelbrecht C, et al.: The effects of treatment failure generalize across different routes of drug administration. Sci Transl Med 2017;9:eaal2999
Kessner S, Wiech K, Forkmann K, et al.: The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Intern Med 2013;173:1468–9
Kessner S, Forkmann K, Ritter C, et al.: The effect of treatment history on therapeutic outcome: psychological and neurobiological underpinnings. PLoS One 2014;9:e109014
Rheker J, Winkler A, Doering BK, et al.: Learning to experience side effects after antideressant intake - results from a randomized, controlled, double-blind study. Psychopharmacology (Berl) 2017;234:329–38
Jensen KB, Kaptchuk TJ, Kirsch I, et al.: Nonconscious activation of placebo and nocebo pain responses. Proc Natl Acad Sci 2012;109:15959–64
Van Den Bergh O, Winters W, Devriese S, et al.: Learning subjective health complaints. Scand J Psychol 2002;43:147–52
Jensen KB, Kaptchuk TJ, Chen X, et al.: A neural mechanism for nonconscious activation of conditioned placebo and nocebo responses. Cereb Cortex 2015;25:3903–10
Kamen C, Tejani MA, Chandwani K, et al.: Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 2014;722:172–9
Stockhorst U, Enck P, Klosterhalfen S: Role of classical conditioning in learning gastrointestinal symptoms. World J Gastroenterol 2007;13:3430–7
Papoiu ADP, Wang H, Coghill RC, et al.: Contagious itch in humans: a study of visual “transmission” of itch in atopic dermatitis and healthy subjects. Br J Dermatol 2011;164:1299–303
Lloyd DM, Hall E, Hall S, et al.: Can itch-related visual stimuli alone provoke a scratch response in healthy individuals? Br J Dermatol 2013;168:106–11
Benedetti F, Durando J, Vighetti S: Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenase-prostaglandins pathway. Pain 2014;155:921–8
Mink JW: Conversion disorder and mass psychogenic illness in child neurology. Ann N Y Acad Sci 2013;1304:40–4
Sirois F: Epidemic hysteria. Acta Psychiatr Scand 1974;50:7–46
Bartholomew RE, Wessely S: Protean nature of mass sociogenic illness: from possessed nuns to chemical and biological terrorism fears. Br J Psychiatry 2002;180:300–6
Petrie KJ, Broadbent EA, Kley N, et al.: Worries about modernity predict symptom complaints after environmental pesticide spraying. Psychosom Med 2005;67:778–82
Page LA, Keshishian C, Leonardi G, et al.: Frequency and predictors of mass psychogenic illness. Epidemiology 2010;21:744–7
Chapman S, St George A, Waller K, et al.: The pattern of complaints about Australian wind farms does not match the establishment and distribution of turbines: support for the psychogenic, 'communicated disease' hypothesis. PLoS One 2013;8:e76584
Balasundaram AP, Athens J, Schneiders AG, et al.: The influence of psychological and lifestyle factors on the reporting of postconcussion-like symptoms. Arch Clin Neuropsychol 2016;31:197–205
Faasse K, Gamble G, Cundy T, et al.: Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre-post observational study. BMJ Open 2012;2:e001607
Faasse K, Cundy T, Petrie KJ: Medicine and the media. Thyroxine: anatomy of a health scare. BMJ 2009;339:b5613
Matthews A, Herrett E, Gasparrini A, et al.: Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data. BMJ 2016;353:i3283
Nielsen SF, Nordestgaard BG: Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. Eur Heart J 2016;37:908–16
Koyama T, McHaffie JG, Laurienti PJ, et al.: The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A 2005;102:12950–5
Freeman S, Yu R, Egorova N, et al.: Distinct neural representations of placebo and nocebo effects. Neuroimage 2015;112:197–207
Kong J, Gollub RL, Polich G, et al.: A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 2008;28:13354–62
Schmid J, Bingel U, Ritter C, et al.: Neural underpinnings of nocebo hyperalgesia in visceral pain: a fMRI study in healthy volunteers. Neuroimage 2015;120:114–22
Bingel U, Wanigasekera V, Wiech K, et al.: The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011;3:70ra14
Johansen O, Brox J, Flaten MA: Placebo and nocebo responses, cortisol, and circulating beta-endorphin. Psychosom Med 2003;65:786–90
Benedetti F, Amanzio M, Vighetti S, et al.: The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006;26:12014–22
Benedetti F, Amanzio M, Casadio C, et al.: Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 1997;71:135–40
Colloca L, Benedetti F: Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 2007;20:435–9
Scott DJ, Stohler CS, Egnatuk CM, et al.: Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008;65:220–31
Schachter S, Singer JE: Cognitive, social, and physiological determinants of emotional state. Psychol Rev 1962;69:379–99
Barsky A: Patients who amplify bodily sensations. Ann Intern Med 1979;91:63–70
Barsky AJ, Klerman GL: Overview: hypochondriasis, bodily complaints, and somatic styles. Am J Psychiatry 1983;140:273–83
Pennebaker J, Skelton J: Selective monitoring of physical sensations. J Pers Soc Psychol 1981;41:213–23
Moss-Morris R, Petrie K: Link between psychiatric dysfunction and dizziness. Lancet 1999;353:515–6
Petrie KJ, Moss-Morris R, Grey C, et al.: The relationship of negative affect and perceived sensitivity to symptom reporting following vaccination. Br J Health Psychol 2004;9:101–11
Feldman PJ, Cohen S, Doyle WJ, et al.: The impact of personality on the reporting of unfounded symptoms and illness. J Pers Soc Psychol 1999;77:370–8
Anchisi D, Zanon M: A Bayesian perspective on sensory and cognitive integration in pain perception and placebo analgesia. PLoS One 2015;10:e0117270
Büchel C, Geuter S, Sprenger C, et al.: Placebo analgesia: a predictive coding perspective. Neuron 2014;81:1223–39
Wiech K: Deconstructing the sensation of pain: the influence of cognitive processes on pain perception. Science 2016;354:584–7
Henningsen P, Gündel H, Kop WJ, et al.: EURONET-SOMA Group. Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom Med 2018;80:422–31
Hall KT, Loscalzo J, Kaptchuk TJ: Genetics and the placebo effect: the placebome. Trends Mol Med 2015;21:285–94
Wendt L, Albring A, Benson S, et al.: Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses. PLoS One 2014;9:e107665
Wang RS, Hall KT, Giulianini F, et al.: Network analysis of the genomic basis of the placebo effect. JCI insight 2017;2:93911
Ferrari R, Constantoyannis C, Papadakis N: Cross-cultural study of symptom expectation following minor head injury in Canada and Greece. Clin Neurol Neurosurg 2001;103:254–9
Ferrari R, Obelieniene D, Russell AS, et al.: Symptom expectation after minor head injury. A comparative study between Canada and Lithuania. Clin Neurol Neurosurg 2001;103:184–90
Whittaker R, Kemp S, House A: Illness perceptions and outcome in mild head injury: a longitudinal study. J Neurol Neurosurg Psychiatry 2007;78:644–6
Hou R, Moss-Morris R, Peveler R, et al.: When a minor head injury results in enduring symptoms: a prospective investigation of risk factors for postconcussional syndrome after mild traumatic brain injury. J Neurol Neurosurg Psychiatry 2012;83:217–23
Snell DL, Hay-Smith EJC, Surgenor LJ, et al.: Examination of outcome after mild traumatic brain injury: the contribution of injury beliefs and Leventhal's common sense model. Neuropsychol Rehabil 2013;23:333–62
Ozen LJ, Fernandes MA: Effects of “diagnosis threat” on cognitive and affective functioning long after mild head injury. J Int Neuropsychol Soc 2011;17:219–29
Suhr JA, Gunstad J: “Diagnosis threat”: the effect of negative expectations on cognitive performance in head injury. J Clin Exp Neuropsychol 2002;24:448–57
Suhr JA, Gunstad J: Further exploration of the effect of “diagnosis threat” on cognitive performance in individuals with mild head injury. J Int Neuropsychol Soc 2005;11:23–9
Kit KA, Mateer CA, Tuokko HA, et al.: Influence of negative stereotypes and beliefs on neuropsychological test performance in a traumatic brain injury population. J Int Neuropsychol Soc 2014;20:157–67
Steele CM: A threat in the air. Am Psychol 1997;52:613–29
Weber M, Edwards MG: The effect of brain injury terminology on university athletes' expected outcome from injury, familiarity and actual symptom report. Brain Inj 2010;24:1364–71
Sullivan KA, Edmed SL, Kempe C: The effect of injury diagnosis on illness perceptions and expected postconcussion syndrome and posttraumatic stress disorder symptoms. J Head Trauma Rehabil 2014;29:54–64
McKinlay A, Bishop A, McLellan T: Public knowledge of “concussion” and the different terminology used to communicate about mild traumatic brain injury (MTBI). Brain Inj 2011;25(7–8):761–6
Mittenberg W, DiGiulio DV, Perrin S, et al.: Symptoms following mild head injury: expectation as aetiology. J Neurol Neurosurg Psychiatry 1992;55:200–4
Gunstad J, Suhr JA: “Expectation as etiology” versus “the good old days”: postconcussion syndrome symptom reporting in athletes, headache sufferers, and depressed individuals. J Int Neuropsychol Soc 2001;7:323–33
Lange RT, Iverson GL, Rose A: Post-concussion symptom reporting and the “good-old-days” bias following mild traumatic brain injury. Arch Clin Neuropsychol 2010;25:442–50
Ferguson RJ, Mittenberg W, Barone DF, et al.: Postconcussion syndrome following sports-related head injury: expectation as etiology. Neuropsychology 1999;13:582–9
Reidenberg M, Lowenthal D: Adverse nondrug reactions. N Engl J Med 1968;279:678–9
Ihlebaek C, Eriksen HR, Ursin H: Prevalence of subjective health complaints (SHC) in Norway. Scand J Public Health 2002;30:20–9
Iverson GL, Lange RT: Examination of “postconcussion-like” symptoms in a healthy sample. Appl Neuropsychol 2003;10:137–44
Gouvier WD, Cubic B, Jones G, et al.: Postconcussion symptoms and daily stress in normal and head-injured college populations. Arch Clin Neuropsychol 1992;7:193–211
Hanna-Pladdy B, Berry ZM, Bennett T, et al.: Stress as a diagnostic challenge for postconcussive symptoms: sequelae of mild traumatic brain injury or physiological stress response. Clin Neuropsychol 2001;15:289–304
Wood RL, O'Hagan G, Williams C, et al.: Anxiety sensitivity and alexithymia as mediators of postconcussion syndrome following mild traumatic brain injury. J Head Trauma Rehabil 2014;29:E9–17
Root JM, Zuckerbraun NS, Wang L, et al.: History of somatization is associated with prolonged recovery from concussion. J Pediatr 2016;174:39–44.e1
Lee JEC, Garber B, Zamorski MA: Prospective analysis of premilitary mental health, somatic symptoms, and postdeployment postconcussive symptoms. Psychosom Med 2015;77:1006–17
Perrine K, Gibaldi JC: Somatization in post-concussion syndrome: a retrospective study. Cureus 2016;8:e743
Nelson LD, Tarima S, LaRoche AA, et al.: Preinjury somatization symptoms contribute to clinical recovery after sport-related concussion. Neurology 2016;86:1856–63
Silverberg ND, Iverson GL, Panenka W: Cogniphobia in mild traumatic brain injury. J Neurotrauma 2017;34:2141–6
Schmidt AJ: Does ‘mental kinesiophobia’ exist? Behav Res Ther 2003;41:1243–9
Kwakkel G, Veerbeek JM, van Wegen EEH, et al.: Constraint-induced movement therapy after stroke. Lancet Neurol 2015;14:224–34
Langer N, Hänggi J, Müller NA, et al.: Effects of limb immobilization on brain plasticity. Neurology 2012;78:182–8
Silverberg ND, Iverson GL: Is rest after concussion “the best medicine?”: recommendations for activity resumption following concussion in athletes, civilians, and military service members. J Head Trauma Rehabil 2013;28:250–9
Thomas DG, Apps JN, Hoffmann RG, et al.: Benefits of strict rest after acute concussion: a randomized controlled trial. Pediatrics 2015;135:213–23
Murray DA, Meldrum D, Lennon O: Can vestibular rehabilitation exercises help patients with concussion? A systematic review of efficacy, prescription and progression patterns. Br J Sports Med 2016;51:442–51
Sarmiento K, Hoffman R, Dmitrovsky Z, et al.: A 10-year review of the Centers for Disease Control and Prevention's Heads Up initiatives: bringing concussion awareness to the forefront. J Safety Res 2014;50:143–7
Rose SC, McNally KA, Heyer GL: Returning the student to school after concussion: what do clinicians need to know? Concussion 2017;1:CNC4
Kroshus E, Daneshvar DH, Baugh CM, et al.: NCAA concussion education in ice hockey: an ineffective mandate. Br J Sports Med 2014;48:135–40
Kurowski BG, Pomerantz WJ, Schaiper C, et al.: Impact of preseason concussion education on knowledge, attitudes, and behaviors of high school athletes. J Trauma Acute Care Surg 2015;79(3 Suppl 1):S21–8
Cook DJ, Cusimano MD, Tator CH, et al.: Evaluation of the ThinkFirst Canada, Smart Hockey, brain and spinal cord injury prevention video. Inj Prev 2003;9:361–6
Bagley AF, Daneshvar DH, Schanker BD, et al.: Effectiveness of the SLICE program for youth concussion education. Clin J Sport Med 2012;22:385–9
Stead TS, Rastogi V, Hedna VS, et al.: Awareness of the CDC “Heads Up!” to Youth Sports Campaign among Pediatric Sports Coaches: a pilot survey study. Cureus 2016;8:e755
Block C, Fabrizio K, Bagley B, et al.: Assessment of veteran and caregiver knowledge about mild traumatic brain injury in a VA Medical Center. J Head Trauma Rehabil 2014;29:76–88
Merz ZC, Van Patten R, Lace J: Current public knowledge pertaining to traumatic brain injury: influence of demographic factors, social trends, and sport concussion experience on the understanding of traumatic brain injury sequelae. Arch Clin Neuropsychol 2017;32:155–67
McKee AC, Stein TD, Kiernan PT, et al.: The neuropathology of chronic traumatic encephalopathy. Brain Pathol 2015;25:350–64
Mez J, Daneshvar DH, Kiernan PT, et al.: Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA 2017;318:360–70
Ahmed OH, Hall EE: “It was only a mild concussion”: exploring the description of sports concussion in online news articles. Phys Ther Sport 2017;23:7–13
Alosco ML, Mez J, Tripodis Y, et al.: Age of first exposure to tackle football and chronic traumatic encephalopathy. Ann Neurol 2018;83:886–901
Montenigro PH, Alosco ML, Martin BM, et al.: Cumulative head impact exposure predicts later-life depression, apathy, executive dysfunction, and cognitive impairment in former high school and college football players. J Neurotrauma 2017;34:328–40
Zafonte RD: Traumatic brain injury: an enduring challenge. Lancet Neurol 2017;16:766–8
Wortzel HS, Brenner LA, Arciniegas DB: Traumatic brain injury and chronic traumatic encephalopathy: a forensic neuropsychiatric perspective. Behav Sci Law 2013;31:721–38
Casson IR, Viano DC, Haacke EM, et al.: Is there chronic brain damage in retired NFL players? Neuroradiology, neuropsychology, and neurology examinations of 45 retired players. Sports Health 2014;6:384–95
Solomon G: Chronic traumatic encephalopathy in sports: a historical and narrative review. Dev Neuropsychol 2018;43:279–311
Iverson GL: Suicide and chronic traumatic encephalopathy. J Neuropsychiatry Clin Neurosci 2016;28:9–16
Pascual-Leone A, Zafonte R: Chronic traumatic encephalopathy and age of first exposure to American-style football. Ann Neurol 2018;83:884–5
Asken BM, Sullan MJ, Snyder AR, et al.: Factors influencing clinical correlates of chronic traumatic encephalopathy (CTE): a review. Neuropsychol Rev 2016;26:340–63
Hux K, Schram CD, Goeken T: Misconceptions about brain injury: a survey replication study. Brain Inj 2006;20:547–53
Baxendale S: Memories aren’t made of this: amnesia at the movies. BMJ 2004;329:1480–3
Guilmette TJ, Paglia MF: The public's misconception about traumatic brain injury: a follow up survey. Arch Clin Neuropsychol 2004;19:183–9
Block CK, West SE, Goldin Y: Misconceptions and misattributions about traumatic brain injury: an integrated conceptual framework. PM R 2016;8:58–68.e4
Carroll LJ, Cassidy JD, Peloso PM, et al.: WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. Prognosis for mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on mild traumatic brain injury. J Rehabil Med 2004;(43 Suppl):84–105
University of Pittsburgh Medical Center: How Knowledgeable Are Americans About Concussions? Harris Poll; 2015. Available at: http://rethinkconcussions.upmc.com/wp-content/uploads/2015/09/harris-poll-report.pdf Accessed December 20, 2018
Silverberg ND, Iverson GL, McCrea M, et al.: Activity-related symptom exacerbations after pediatric concussion. JAMA Pediatr 2016;170:946–53
Vanderploeg RD, Belanger HG, Kaufmann PM: Nocebo effects and mild traumatic brain injury: legal implications. Psychol Inj Law 2014;7:245–54
Baron SL, Hein MJ, Lehman E, et al.: Body mass index, playing position, race, and the cardiovascular mortality of retired professional football players. Am J Cardiol 2012;109:889–96
Riley ET: Chronic traumatic encephalopathy and professional athletes: suicides are contagious. World Neurosurg 2016;94:576–7
Dunne T: Jamal Lewis making most of his post-NFL life—but preparing for darker days to come. Bleacher Report 2018
Bieler D: Terrel Davis on CTE: “we're all scared.”. Wash Post 2017
Bonesteel M: Former NHL enforcer Todd Ewen, who committed suicide, found to not have CTE. Wash Post. Available at: https://www.washingtonpost.com/news/early-lead/wp/2016/02/11/former-nhl-enforcer-todd-ewen-who-committed-suicide-found-to-not-have-cte/?utm_term=.2e61f6c2932f Accessed December 1, 2018
McCarthy M: The hidden victims of the NFL's concussion crisis. Deadspin. Available at: https://deadspin.com/the-hidden-victims-of-the-nfls-concussion-crisis-1443101890 Accessed December 1, 2018
Stack S: Media coverage as a risk factor in suicide. J Epidemiol Community Health 2003;57:238–40
Etzersdorfer E, Voracek M, Sonneck G: A dose-response relationship between imitational suicides and newspaper distribution. Arch Suicide Res 2004;8:137–45
Schwarz A: Before suicide, Duerson said he wanted brain study. New York Times. Available at: https://www.nytimes.com/2011/02/20/sports/football/20duerson.html Accessed December 1, 2018
Forgave R: The concussion diaries: one high school football player's secret struggle with CTE. GQ. Available at: https://www.gq.com/story/the-concussion-diaries-high-school-football-cte Published 2017
Smith S: Lives after junior. ESPN. Available at: http://www.espn.com/nfl/story/_/id/9410051/a-year-later-one-junior-seau-close-friends-comes-forward-recount-version-descent Accessed December 1, 2018
Mesoudi A: The cultural dynamics of copycat suicide. PLoS One 2009;4:e7252
Ponsford J, Willmott C, Rothwell A, et al.: Impact of early intervention on outcome following mild head injury in adults. J Neurol Neurosurg Psychiatry 2002;73:330–2
Bell KR, Hoffman JM, Temkin NR, et al.: The effect of telephone counselling on reducing post-traumatic symptoms after mild traumatic brain injury: a randomised trial. J Neurol Neurosurg Psychiatry 2008;79:1275–81
Suffoletto B, Wagner AK, Arenth PM, et al.: Mobile phone text messaging to assess symptoms after mild traumatic brain injury and provide self-care support: a pilot study. J Head Trauma Rehabil 2013;28:302–12
Matuseviciene G, Eriksson G, DeBoussard CN: No effect of an early intervention after mild traumatic brain injury on activity and participation: a randomized controlled trial. J Rehabil Med 2016;48:19–26
Matuseviciene G, Borg J, Stalnacke B-M, et al.: Early intervention for patients at risk for persisting disability after mild traumatic brain injury: a randomized, controlled study. Brain Inj 2013;27:318–24
Hiploylee C, Dufort PA, Davis HS, et al.: Longitudinal study of postconcussion syndrome: not everyone recovers. J Neurotrauma 2017;34:1511–23